NAVIGO PURE
LIVE

Serial Number

79450055

Owner

Navigo Proteins GmbH

Filing Date

Mar 17, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NAVIGO PURE Trademark

Serial Number: 79450055

NAVIGO PURE is a trademark filed by Navigo Proteins GmbH on March 17, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Navigo Proteins GmbH (9 trademarks)

Heinrich-Damerow-Str. 1
Halle 06120 , DE

Entity Type: 99

Trademark Details

Filing Date

March 17, 2026

Registration Date

Not Registered

Goods & Services

Chemical, biological, analytical, and/or chromatographic substances, active agents, and/or compositions, in particular containing proteins, polypeptides, peptides, for industrial and scientific applications, including laboratory analysis, in particular purification methods, other than for medical and veterinary use.

Analytical, biological, chemical, chromatographical biochemical, diagnostic, therapeutic substances, active ingredients, and/or compositions, in particular containing proteins, polypeptides, peptides, for diagnostic and therapeutic applications.

Scientific, technological and industrial services and research, in particular in the pharmaceutical, diagnostic, analytical or biochemical field; services and research and development work for purification, identification, further development and application of analytical, biochemical, pharmaceutical, diagnostic or therapeutic goods; molecular biological, biotechnological, biochemical or pharmaceutical laboratory services; services and research and development work in the field of chromatography; services and research and development work in the field of purification, identification, screening and production of analytical, biochemical, pharmaceutical, diagnostic and therapeutic goods, in particular proteins, polypeptides, peptides, antibodies, fusion proteins, enzymes, hormones, blood factors, vaccines, virus vectors, virus-like particles, cells, rna and test kits; services and research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological, biochemical or genetic methods.

Filing History

APPLICATION FILING RECEIPT MAILED
May 20, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 14, 2026 REPR